|
2007P-0237:
Clear New Susceptibility Test devices or Modification of Existing
Devices using Clinical and Laboratory Standards Institute (CLSI)
Interpretive Breakpoints in those Instances Regarding Susceptibility
Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 06/08/2007
|
| 06/08/2007
|
| Private Industry
|
| Clinical and Laboratory
Standards Institute
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Robert Habig, PhD & Glen
Fine, MS, M
|
|
|
|
|
| ACK1
|
| 06/18/2007
|
| 06/18/2007
|
| Federal Government
|
| FDA/DDM to Clinical
and Laboratory Standards Institute
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
| |
|
|
Top
| Up
Page last updated:
July 9, 2007
|